Evidence map›Paper›PMID 40775829›Full record

ArticleStudies in health technology and informatics2025

A Pilot Meta-Research on Evolving Evidence Behind Genetic Variant (Re)Classification.

Haotian Ma, Zihan Xu, Wendy Chung, Chunhua Weng, Yifan Peng

Abstract read
In one paragraph

Article in Studies in health technology and informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Haotian MaWeill Cornell Medicine, New York, NY, US.
Zihan XuWeill Cornell Medicine, New York, NY, US.
Wendy ChungBoston Children's Hospital and Harvard Medical School, Boston, MA, US.
Chunhua WengColumbia University, New York, NY, US.
Yifan PengWeill Cornell Medicine, New York, NY, US.

Funding

ClinEX - Clinical Evidence Extraction, Representation, and AppraisalR01LM014344 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Yong Chen, Yifan Peng · 2023 to 2026
$2.7M
Extraction and summarization of evidence-based medicineR01LM014573 · NLM · WEILL MEDICAL COLL OF CORNELL UNIV · PI Yifan Peng, CHUNHUA WENG · 2024 to 2026
$1.1M
NLM NIH HHS R01 LM014344NLM NIH HHS R01 LM014573
6 · The paper itself

Abstract

Variant classification and reclassification are fundamental to advancing precision medicine. This study focuses on the reclassifications of variants of uncertain significance (VUS) in BRCA1 and BRCA2 genes. By analyzing 162 unique cited publications supporting VUS reclassifications, we examined the accuracy, completeness, and currency of citations to these publications. Our findings reveal missing or inadequate evidence for reclassifications, as well as temporally misaligned citations and ClinVar submissions. Furthermore, we observed patterns in the cited studies, including the use of classification recommendations, genetic mechanisms, computational tools, and diverse population studies. This study underscores the need for stronger evidence supporting reclassifications and greater inclusion of diverse populations to optimize genomic variant reclassification and clinical decision-making.

Indexed as

Genetic VariationBRCA1 ProteinGenes, BRCA1HumansPilot ProjectsPrecision MedicineBRCA1 Proteingenetic variantmeta-researchmutationvariant reclassification

Identifiers

PMID40775829
PMCPMC12976955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.